ACC Cardiology Hour | AHA 2023

In the latest installment of ACC Cardiology Hour, Valentin Fuster, MD, PhD, MACC, is joined by expert panelists Joshua A. Beckman, MD, MS, FACC; Roxana Mehran, MD, FACC; Pasquale Santangeli, MD, PhD; and Amanda Vest, MD, in a lively discussion on top late-breaking clinical trials released during AHA's Scientific Sessions 2023. Watch for key takeaways and practice implications of trials including SELECT (3:01), ARTESIA (14:51), AZALEA-TIMI 71 (23:34), ORBITA-2 (33:50). Efficacy and Safety of Lepodisiran (43:26), VERVE-101 (50:43) and KARDIA-1 (58:33). Don't miss the panelists "best of AHA" selections (1:04:32).

A long-standing resource for busy cardiovascular professionals, ACC Cardiology Hour offers multidisciplinary expert discussion on top clinical trials released during cardiology's biggest meetings. Visit to see more videos.

The ACC is providing coverage of the latest science being presented at AHA 2023 in Philadelphia. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage Page. Follow the ACC on Social Media and use the hashtag #AHA23.

Clinical Topics: Arrhythmias and Clinical EP, Diabetes and Cardiometabolic Disease, Dyslipidemia, Prevention, Atrial Fibrillation/Supraventricular Arrhythmias, Hypertension, Vascular Medicine, Invasive Cardiovascular Angiography and Intervention, Acute Coronary Syndromes, Anticoagulation Management

Keywords: American Heart Association, AHA23, Dyslipidemias, PCSK9, Atrial Fibrillation, Stroke, Glucagon-Like Peptide-1 Receptor, Obesity, Anticoagulation Management, Myocardial Ischemia, Blood Pressure, Hypertension, RNA Interference

< Back to Listings